These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Pollard JA; Wallace RJ; Nash DR; Luman JI; Wilson RW Drugs; 1986; 31 Suppl 3():103-8. PubMed ID: 3488188 [TBL] [Abstract][Full Text] [Related]
15. Novel beta-lactamase from Branhamella catarrhalis. Hoi-Dang AB; Brive-Le Bouguenec C; Barthelemy M; Labia R Ann Microbiol (Paris); 1978 Oct; 129 B(3):397-406. PubMed ID: 311606 [TBL] [Abstract][Full Text] [Related]
16. Direct and indirect pathogenicity of Branhamella catarrhalis. Brook I Drugs; 1986; 31 Suppl 3():97-102. PubMed ID: 3488202 [TBL] [Abstract][Full Text] [Related]
17. Bronchopulmonary infection due to Branhamella catarrhalis. McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451 [TBL] [Abstract][Full Text] [Related]
18. Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species. Labia R; Barthelemy M; Le Bouguennec CB; Buu Hoi-Dang Van A Drugs; 1986; 31 Suppl 3():40-7. PubMed ID: 3488196 [TBL] [Abstract][Full Text] [Related]